Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mixed Panniculitis Secondary to Interferon beta-1a Therapy in a Woman With Multiple Sclerosis.
The axes of access--improving care for patients with disabilities.
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
Chronic pain following spinal cord injury.
Self-reported health promotion and disability progression in multiple sclerosis.
Paraneoplastic and other autoimmune disorders of the central nervous system.
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
The pathogenic role of the inflammasome in neurodegenerative diseases.
Limb ataxia originating from peri-central sulcus demyelinating lesion in multiple sclerosis.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
Multidisciplinary team care in rehabilitation: On overview of reviews.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Assisted reproduction technology in multiple sclerosis: Giving birth to a new avenue of research in hormones and autoimmunity.
Color-Code Agreement Among Stratus, Cirrus, and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis With and Without Prior Optic Neuritis.
Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis.
Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report.
Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis (EAE).
An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis.
Targeting NOX enzymes in the central nervous system: therapeutic opportunities.
[The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis.]

Pages